Trust Agreements in the Biotechnology Industry
26 Contracts & Agreements
- ADURO BIOTECH, INC. (1 contract)
- AquaBounty Technologies, Inc. (2)
- Arbutus Biopharma Corp (1)
- BioLife4D Corp (2)
- BioRestorative Therapies, Inc. (1)
- Bison Capital Acquisition Corp. (2)
- CONCERT PHARMACEUTICALS, INC. (1)
- Cytokinetics, Incorporated (1)
- ENZON PHARMACEUTICALS, INC. (1)
- IMMUCELL CORP (1)
- LEAP THERAPEUTICS, INC. (1)
- Magenta Therapeutics, Inc. (1)
- MeiraGTx Holdings plc (1)
- Morphic Holding, Inc. (2)
- Ohr Pharmaceutical Inc (1)
- OncBioMune Pharmaceuticals, Inc (1)
- Spring Bank Pharmaceuticals, Inc. (2)
- United Therapeutics Corp (1)
- Unum Therapeutics Inc. (1)
- Vanda Pharmaceuticals Inc. (1)
- XOMA Corp (1)
- Letter Agreement dated August 26, 2021 between Presidio Trust and Kinnate Biopharma Inc (XOMA Corp, Filed With SEC on August 13, 2024)
- Tender and Support Agreement, dated as of July 7, 2024, by and among Eli Lilly and Company, Rainier Acquisition Corporation, Praveen Tipirneni and The Praveen Tipirneni... (Morphic Holding, Inc., Filed With SEC on July 8, 2024)
- Tender and Support Agreement, dated as of July 7, 2024, by and among Eli Lilly and Company, Rainier Acquisition Corporation, Timothy Springer, Chafen Lu, Springer-Lu Family 2004... (Morphic Holding, Inc., Filed With SEC on July 8, 2024)
- Subordination,Non-Disturbance and Attornment Agreement by and among, the Company, Univest Bank and Trust Co., and Veterans Circle Group, LLC dated December 12, 2023 (Arbutus Biopharma Corp, Filed With SEC on March 5, 2024)
- Amendment No. 1 to Stockholder Rights Agreement, dated as of May 2, 2023, by and between Magenta Therapeutics, Inc. and Computershare Trust Company, N.A., as Rights Agent (Magenta Therapeutics, Inc., Filed With SEC on May 3, 2023)
- Contingent Value Rights Agreement, dated as of March 6, 2023, by and among Sun Pharmaceutical Holdings USA, Inc., Sun Pharmaceutical Industries Ltd., Computershare Inc. and... (CONCERT PHARMACEUTICALS, INC., Filed With SEC on March 6, 2023)
- Support Agreement by and between Leap Therapeutics, Inc. and HealthCare Ventures VIII Liquidating Trust, dated January 17, 2023 (LEAP THERAPEUTICS, INC., Filed With SEC on January 23, 2023)
- Agreement, dated December 6, 2022, between BioLife4D Corporation and BioLife4D SM Trust, dated November 1, 2016 (BioLife4D Corp, Filed With SEC on December 19, 2022)
- Agreement, dated May 18, 2022, between BioLife4D Corporation and BioLife4d SM Trust, dated November 1, 2016 (BioLife4D Corp, Filed With SEC on June 3, 2022)
- STING Antagonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare... (Spring Bank Pharmaceuticals, Inc., Filed With SEC on November 20, 2020)
- STING Agonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare Inc.,... (Spring Bank Pharmaceuticals, Inc., Filed With SEC on November 20, 2020)
- Contingent Value Rights Agreement, dated October 2, 2020, by and between Aduro Biotech, Inc. and Computershare Trust Company, N.A (ADURO BIOTECH, INC., Filed With SEC on November 5, 2020)
- Section 382Rights Agreement Datedas of August 14, 2020 byand between ENZON PHARMACEUTICALS, INC. and CONTINENTALSTOCK TRANSFER & TRUST COMPANY as Rights Agent (ENZON PHARMACEUTICALS, INC., Filed With SEC on August 14, 2020)
- Contingent Value Rights Agreement, dated as of August 6, 2020, by and among Unum Therapeutics Inc., Computershare Inc. and Computershare Trust Company, N.A (Unum Therapeutics Inc., Filed With SEC on August 10, 2020)
- Environmental Indemnity Agreement by and among AquaBounty Technologies, Inc., AquaBounty Farms Indiana LLC, and First Farmers Bank and Trust, dated as of July 31, 2020 (AquaBounty Technologies, Inc., Filed With SEC on August 6, 2020)
- Collateral Access Agreement by and between AquaBounty Technologies, Inc. and First Farmers Bank and Trust, dated as of July 31, 2020 (AquaBounty Technologies, Inc., Filed With SEC on August 6, 2020)
- Amendment No. 1 to Trust Agreement, dated March 21, 2019, by and between Bison Capital Acquisition Corp. and Continental Stock Transfer & Trust Company (Bison Capital Acquisition Corp., Filed With SEC on March 22, 2019)
- Form of Amended Trust Agreement (Bison Capital Acquisition Corp., Filed With SEC on March 5, 2019)
- Irrevocable Trust Agreement Number F/2868 entered into among Manuel Cosme Odabachian, Carlos Fernando Alaman Volnie and OncBioMune Pharmaceuticals, Inc. as beneficiaries and Banco... (OncBioMune Pharmaceuticals, Inc, Filed With SEC on February 21, 2019)
- Overage Deed, dated December 14, 2018, between Moorfields Eye Hospital NHS Foundation Trust and MeiraGTx UK II Limited relating to the Pharmacy Manufacturing Unit, Britannia Walk,... (MeiraGTx Holdings plc, Filed With SEC on December 20, 2018)
- Letter agreement, dated as of July 5, 2017, between BioRestorative Therapies, Inc. and Tuxis Trust (BioRestorative Therapies, Inc., Filed With SEC on October 5, 2017)
- ROYALTYPURCHASE AGREEMENT BY AND BETWEEN CYTOKINETICS, INCORPORATED AND RPIFINANCE TRUST DATED AS OF FEBRUARY 1, 2017 TABLE OF CONTENTS (Cytokinetics, Incorporated, Filed With SEC on March 6, 2017)
- ASSETPURCHASE AGREEMENT datedAugust 21, 2009 between OHRPHARMACEUTICAL, INC. and GENAERALIQUIDATING TRUST (Ohr Pharmaceutical Inc, Filed With SEC on August 26, 2009)
- IMMUCELL CORPORATION and AMERICAN STOCK TRANSFER & TRUST CO. Rights Agent (IMMUCELL CORP, Filed With SEC on May 5, 2009)
- UNITED THERAPEUTICSCORPORATION SUPPLEMENTAL EXECUTIVE RETIREMENTPLAN RABBI TRUST DOCUMENT (United Therapeutics Corp, Filed With SEC on December 28, 2007)
- EX-10.10: SUMMARY PLAN DESCRIPTION PROVIDED FOR THE 401(K) PROFIT SHARING PLAN & TRUST (Vanda Pharmaceuticals Inc., Filed With SEC on December 29, 2005)
